Attain Assist CS Access Catheter

K171819 · Creganna Medical Also Doing Business AS Ceganna Tactx Medica · DQY · Jan 4, 2018 · Cardiovascular

Device Facts

• Record ID: K171819
• Device Name: Attain Assist CS Access Catheter
• Applicant: Creganna Medical Also Doing Business AS Ceganna Tactx Medica
• Product Code: DQY · Cardiovascular
• Decision Date: Jan 4, 2018
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 870.1250
• Device Class: Class 2

Intended Use

The Attain Assist™ CS Access Catheter is a left-heart CS catheter intended to enable access to the left heart via the coronary sinus.

Device Story

Attain Assist CS Access Catheter is a sterile, single-use intravascular catheter; facilitates left heart access via coronary sinus. Device features braid-reinforced shaft, distal curve, hub luer connection, and detachable cap to prevent leakage. Six radiopaque marker bands embedded at distal end provide visualization under fluoroscopy; stainless steel tip ensures atraumatic lead during delivery. Designed for insertion within guide catheters (inner diameter ≥ 6.5Fr). Used by physicians in interventional coronary procedures. Provides stable access path for secondary devices; benefits patient by enabling minimally invasive left-heart interventions.

Clinical Evidence

No clinical data. Substantial equivalence demonstrated via bench testing only. Biocompatibility testing performed per ISO 10993-1 (cytotoxicity, sensitization, irritation, systemic toxicity, hemocompatibility, thromboresistance, pyrogenicity). Design verification and validation testing confirmed catheter performance (tensile strength, pressure integrity, kink resistance, torque response, trackability, radiopacity).

Technological Characteristics

Braid-reinforced catheter shaft; stainless steel tip; six radiopaque marker bands. Materials biocompatible per ISO 10993-1. Single-use, sterile. Compatible with guide catheters ≥ 6.5Fr. Mechanical sensing/actuation via manual manipulation under fluoroscopic guidance.

Indications for Use

Indicated for patients requiring access to the left heart via the coronary sinus for interventional coronary procedures.

Regulatory Classification

Identification

A percutaneous catheter is a device that is introduced into a vein or artery through the skin using a dilator and a sheath (introducer) or guide wire.

Predicate Devices

• Attain Command™ + SureValve™ Guide Catheter (K123153)

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the seal of the Department of Health & Human Services. To the right of that is the FDA logo, which is a blue square with the letters "FDA" in white. To the right of the FDA logo is the text "U.S. FOOD & DRUG ADMINISTRATION" in blue.

Creganna Medical Olivia Odhiambo Senior Regulatory Affairs Specialist Parkmore West Galway, Ireland

Re: K171819

Trade/Device Name: Attain Assist CS Access Catheter Regulation Number: 21 CFR 870.1250 Regulation Name: Percutaneous Catheter Regulatory Class: Class II Product Code: DOY Dated: December 6, 2017 Received: December 6, 2017

## Dear Olivia Odhiambo:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820);

{1}------------------------------------------------

1000-1050.

and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR

Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/) and CDRH Learn (http://www.fda.gov/Training/CDRHLearn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (http://www.fda.gov/DICE) for more information or contact DICE by email ([e-mail]) or phone [phone] or 301-796-7100).

Sincerely,

MA Millel

for Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

| DEPARTMENT OF HEALTH AND HUMAN SERVICES<br>Food and Drug Administration | Form Approved: OMB No. 0910-0120<br>Expiration Date: January 31, 2017<br>See PRA Statement below. |
|-------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------|
|-------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------|

**Indications for Use**

| 510(k) Number (if known) | K171819 |
|--------------------------------|---------------------------------------------------------------------------------------------------------------------------------------|
| Device Name | Attain Assist™ CS Access Catheter |
| Indications for Use (Describe) | The Attain Assist™ CS Access Catheter is a left-heart CS catheter intended to enable access to the left heart via the coronary sinus. |

Type of Use (Select one or both, as applicable)

| <span> <svg class="bi bi-check-square-fill" fill="currentColor" height="1em" viewbox="0 0 16 16" width="1em" xmlns="http://www.w3.org/2000/svg"> <path d="M2 0a2 2 0 0 0-2 2v12a2 2 0 0 0 2 2h12a2 2 0 0 0 2-2V2a2 2 0 0 0-2-2H2zm10.03 4.97a.75.75 0 0 0-1.08.022L7.477 9.417 5.384 7.323a.75.75 0 0 0-1.06 1.06L6.97 11.03a.75.75 0 0 0 1.079-.02l3.992-4.99a.75.75 0 0 0-.01-1.05z" fill-rule="evenodd"></path> </svg> Prescription Use (Part 21 CFR 801 Subpart D) </span> | <span> Over-The-Counter Use (21 CFR 801 Subpart C) </span> |
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------|
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|----------------------------------------------------------------------------------------|

#### CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

#### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW .*

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff [e-mail]

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

FORM FDA 3881 (8/14)

Page 1 of 1

POC Publiciting Services (DOI) 440-6749 EF

{3}------------------------------------------------

## 510(k) Summary

#### General Information

| Date: | 15 June 2017 |
|---------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Classification: | Class II, 21 CFR 870.1250, Percutaneous Catheter |
| Product Code: | DQY |
| Trade Name: | Attain Assist™ CS Access Catheter |
| Common Name: | Percutaneous Catheter |
| Model Number(s): | 146168-01 |
| Submitter: | Creganna Medical,<br>Parkmore West,<br>Galway, Ireland |
| Regulatory Contact: | Orla Connaughton<br>Regulatory Affairs Director<br>Creganna Medical<br>Parkmore West<br>Galway, Ireland<br>Tel: + 91 783469<br>Email: [e-mail] |

#### Intended Use

The Attain Assist™ CS Access Catheter is a left-heart CS catheter intended to enable access to the left heart via the coronary sinus.

## Predicate Device

- . Attain Command™ + SureValve™ Guide Catheter, K123153
#### Device Description

The Medtronic Attain Assist™ CS Access Catheter is a sterile, single-use intravascular catheter used to facilitate access to the left heart via the coronary sinus.

The device consists of a braid reinforced catheter shaft with a curve at the distal end and a hub luer connection with a strain relief and a detachable cap at the device. The device. The detachable cap

{4}------------------------------------------------

prevents leakage from the catheter when a guide wire is not being used. At the distal end of the catheter shaft, six (6) radiopaque marker bands are embedded into the shaft which provide a visual aid under fluoroscopy during device positioning in the left heart. A stainless steel tip is attached to the distal edge of the braided catheter shaft to provide an atraumatic lead for the catheter during delivery.

The Attain Assist™ CS Access Catheter is compatible with guide catheters with inner diameter of 6.5Fr or greater.

The device is supplied as a single use sterile device.

#### Materials

The Attain Assist™ CS Access Catheter is comprised of materials that are commonly used in medical device applications, including implantable medical devices. The biological safety tests performed in accordance with ISO 10993-1 (Biological evaluation of medical devices -- Part 1: Evaluation and testing) for external communicating devices, circulating blood, limited duration demonstrate that the device is biocompatible for its intended use.

The tests performed to demonstrate the biocompatibility of the device were:

- . Cytotoxicity
- o Sensitization
- Intracutaneous Reactivity/Irritation
- Acute Systemic Toxicity
- Hemocompatibility
- . Thromboresistance
- . Material Mediated Pyrogenicity

# Comparison of Technological Characteristics of Attain Assist™ CS Access Catheter compared to the Predicate Device

The Attain Assist™ CS Access Catheter and the equivalent commercialized predicate device Attain Command™ + SureValve™ Guide Catheter were evaluated for substantial equivalence. No significant difference in clinical, technical and biological parameters was identified between the Attain Assist™ CS

Access Catheter and the predicate device. Both devices have clinical principal of operation,

i.e. advancement through the same anatomical locations to obtain access to the left heart via the

{5}------------------------------------------------

sinus, in the same patient population with the same user group. Both devices are used in interventional coronary procedures. The technological specifications and characteristics are extremely similar, the slight differences relating primarily to the fact that the predicate device is a guide catheter and the proposed device is intended to be inserted within the guide catheter. Both devices have similar designs and the materials that are used meet the same biological standards. Based on this and the design and engineering data provided, the Attain Assist™ CS Access Catheter has been shown to be substantially equivalent to the commercialized Attain Command™ + SureValve™ Guide Catheter.

#### Non Clinical Information

The determination of substantial equivalence is also based on an assessment of non-clinical engineering tests, as listed in Table 1-1 and Table 1-2.

| Design Verification Tests | |
|---------------------------------------------------------------|-----------------------------------------------|
| Catheter Shaft And Tip Outer Diameter | Catheter Proximal Hub |
| Catheter Working Length | Package Sterility |
| Catheter Curvature | Seal Strength Of Sterile Package |
| Catheter Tensile Strength (Shaft, Hub To Shaft, Tip To Shaft) | Packaging Integrity (Including Seal Width) |
| Catheter Pressure Integrity | Labelling/IFU Integrity And Legibility |
| Catheter Guidewire Interface/Compatibility | Package Contents / Configuration |
| Kink Resistance | Patient Chart Stickers |
| Corrosion Resistance | Catheter Trackability |
| Catheter Shapeability | Ability To Withstand Environmental Conditions |
| Cap fitting (attachment to catheter hub leur) | |

Table 1-1: List of Design Verification Tests

| Design Validation Tests | |
|--------------------------------------------------|-------------------------------------------------------------------------------------|
| Catheter Distal Marker Bands Radiopacity | Cap fitting (attachment to catheter hub leur) |
| Catheter Guidewire<br>interface/compatibility | Compatibility of Attain Assist™ with the Attain<br>Command™ device |
| Catheter Radio-detectability | Catheter Proximal Hub (ergonomic, Grip and handling) |
| Catheter Torque response | Removal of Product from Packaging |
| Catheter Trackability | IFU requirements - (easy to understand, language) |
| Catheter Shapeability | Labelling requirements – Pouch and carton Label (easy to |
| Hub Luer fitting (compatibility with<br>syringe) | understand, language, provide traceability, product<br>identification, expiry date) |

#### Table 1-2: List of Design Validation Tests (Bench)

{6}------------------------------------------------

The test results demonstrate that the Attain Assist™ CS Access Catheter meets the requirements in the applicable standards and specifications and is substantially equivalent to legally marketed predicate device.

#### Clinical Information

Clinical studies were not deemed necessary for the Attain Assist™ CS Access Catheter since bench testing was sufficient to demonstrate substantial equivalence by way of comparison to a legally marketed predicate device.

#### Summary of Substantial Equivalence

Creganna Medical believes the Attain Assist™ CS Access Catheter is substantially equivalent to the predicate device based on the nonclinical literature review as discussed above. The intended of operation, methods of construction and materials used, are either identical or substantially equivalent to an existing legally marketed product (Attain Command™ + SureValve™ Guide Catheter).